Aurobindo Pharma Limited has informed the Exchange regarding Cessation of MRR Assocaites as Other of the company w.e.f. May 22, 2026.
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aurobindo Pharma has announced a change in its Secretarial Auditors. M/s. MRR & Associates has resigned effective May 22, 2026, due to health issues of its sole proprietor. Simultaneously, the Board has appointed M/s. RPR & Associates as the new Secretarial Auditor for a five-year term commencing from FY 2026-27 to FY 2030-31. The appointment is subject to shareholder approval at the ensuing Annual General Meeting. RPR & Associates is a firm of company secretaries with expertise in Corporate Laws, SEBI Regulations and FEMA Regulations.
This is a routine change in auditors driven by the health condition of the outgoing auditor's sole proprietor. The resignation does not indicate any governance concerns or disputes. It should not have any material impact on the company's operations or stock price.